3764 Desert Willow Ad 1.0


Published on

Published in: Health & Medicine, Education
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

3764 Desert Willow Ad 1.0

  1. 1. Molecular Imaging/ Nuclear Medicine Radiological Society of North America 93rd Scientific Assembly and Annual Meeting November 25–30, 2007 McCormick Place, Chicago RSNA2007.RSNA.org SUBSPECIALTY CONTENT BROCHURE
  2. 2. Subspecialty content brochures organize the components of the annual meeting by subjects that correspond to radiologic subspecialties. We hope this brochure, along with the meeting program, helps to enrich and ease your experience at RSNA 2007. RSNA Annual Meeting CME Information RSNA® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. RSNA designates this educational activity for a maximum of 85.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Syllabus = Syllabus available for purchase at the Education Store in RSNA Services, Lakeside Center, Level 3 or at Booth 1200, South Building, Hall A. Sunday, November 25, 2007 10:45-12:15 Scientific Paper Sessions Gastrointestinal (Gastrointestinal Oncology; CT/PET) (Session SSA11) (E451B) ISP: National Oncologic PET Registry—Oncologic PET/CT (Session SSA08) (E353C) 2:00-3:30 Refresher Courses Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—PET Basics (Course RC111) (N228) Essentials of Molecular Imaging for Clinical Radiologists (Course RC117) (N227) Lymph Node Assessment in Oncologic Patients (An Interactive Session) (Course RC118) (S402AB) Monday, November 26, 2007 8:30-10:00 Refresher Courses Cardiovascular Imaging in the Era of Molecular Medicine (Course RC217) (S401CD) Categorical Course in Diagnostic Radiology Physics: Imaging Technologies in Oncology—Imaging Brain Tumors (Course RC221) (S504D) SYLLABUS SYLLABUS
  3. 3. Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—CNS PET (Course RC211) (N228) PET/CT in Oncology I: Lung, Lymphoma, Esophagus (Course RC218) (S406B) 10:30-12:00 Scientific Paper Sessions Molecular Imaging (Applications I) (Session SSC05) (E353A) Nuclear Medicine (PET/CT in Breast and Genitourinary Malignancies) (Session SSC07) (E353C) 3:00-4:00 Scientific Paper Sessions Molecular Imaging (Techniques I) (Session SSE05) (E353A) Nuclear Medicine (Brain and Central Nervous System) (Session SSE07) (E353C) Tuesday, November 27, 2007 8:30-10:00 Multisession Course Fusion Imaging (Sponsored by the Associated Sciences Consortium) (Course AS31) (N230) Refresher Courses Categorical Course in Diagnostic Radiology Physics: Imaging Technologies in Oncology—Imaging Lung Cancer (Course RC321) (S504D) Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—PET of the Thorax (Course RC311) (N228) Neurologic Imaging in the Era of Molecular Medicine (Course RC317) (S504ABC) Patterns of Tumor Spread: From Head and Neck to the Toes (Course RC306) (E451A) Update Course in Diagnostic Radiology: Genitourinary—Imaging in Gynecologic Malignancies (Course RC307) (E350) 10:30-12:00 Scientific Paper Session Nuclear Medicine (PET/CT in Gastrointestinal Malignancies) (Session SSG06) (E353C) 3:00-4:00 Scientific Paper Sessions ISP: Molecular Imaging (Cell Tracking) (Session SSJ06) (E353A) Nuclear Medicine (PET/CT in Lymphoma, Melanoma and Sarcomas) (Session SSJ08) (E353C) SYLLABUS SYLLABUS SYLLABUS
  4. 4. 3:30-5:00 Multisession Course Essentials of Nuclear Medicine (Course ES34) (S100AB) 4:30-6:00 Refresher Courses Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—Abdominopelvic PET/CT and the Medicare PET Registry (Course RC411) (N228) Minicourse in Oncologic Imaging: Imaging as a Biomarker (Course RC428) (S404CD) Oncologic Imaging in the Era of Molecular Medicine (Course RC417) (S501ABC) PET/CT in Oncology II: Head and Neck, Breast, Melanoma (Course RC418) (S503AB) Wednesday, November 28, 2007 8:30-10:00 Multisession Course Molecular Imaging: Introduction and Overview of Molecular Imaging (Course MI41) (S504ABC) Refresher Courses Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—PET of Extracranial Head and Neck and Thyroid Cancer (Course RC511) (N228) Interventional Radiology in the Era of Molecular Medicine (Course RC517) (N226) New Thoracic Imaging Technologies: 64-Slice Multidetector CT, Postprocessing, PET/CT, and Enhanced Radiography Methods (Course RC501) (E451B) 10:30-12:00 Multisession Course Molecular Imaging in Oncology (Course MI42) (S504ABC) Scientific Paper Sessions Molecular Imaging (Applications II) (Session SSK04) (E353A) Nuclear Medicine (PET/CT in Neck and Chest Malignancies) (Session SSK06) (E353C) 1:30-2:45 Multisession Course Molecular Imaging: Cardiovascular Imaging (Course MI43) (S504ABC) 3:00-4:00 Scientific Paper Sessions Breast Imaging (CT and PET) (Session SSM01) (Arie Crown Theater) Molecular Imaging (Techniques II) (Session SSM05) (E352) SYLLABUS SYLLABUS
  5. 5. Nuclear Medicine (General) (Session SSM08) (E353C) 3:15-4:45 Multisession Course Molecular Imaging in Neurology (Course MI44) (S504ABC) 4:30-6:00 Focus Session PET/CT versus PET Alone: Is CT Always Appropriate? (Session SFN08) (E352) Thursday, November 29, 2007 8:30-10:00 Refresher Courses Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—Lymphoma, Melanoma, Sarcomas (Course RC611) (N228) Gastrointestinal Imaging in the Era of Molecular Medicine (Course RC617) (N229) Imaging Musculoskeletal Infections: How to Rationally Integrate Nuclear Medicine Imaging with MR Imaging and CT (Course RC616) (S503AB) Minicourse: Image Optimization for Treatment Planning—Brain, Head and Neck, and Extremities (Course RC622) (S404AB) Minicourse: Innovations and Advances in Medical Imaging Technology—Innovations and Advances in Radionuclide Imaging Technology (Course RC623) (E253CD) New Developments in SPECT and PET of the Heart (Course RC603) (N230) 10:30-12:00 Scientific Paper Sessions ISP: Molecular Imaging (Imaging Agents) (Session SSQ02) (E253CD) Nuclear Medicine (Cardiovascular) (Session SSQ06) (E353C) Physics (Various Modalities: Nuclear Medicine, Optical, MR Imaging) (Session SSQ16) (S401CD) 4:30-6:00 Refresher Courses Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—Clinical Cardiac PET/CT (Course RC711) (N228) GU Imaging in the Era of Molecular Medicine (Course RC717) (S503AB) Friday, November 30, 2007 8:30-10:00 Refresher Courses Breast Imaging in the Era of Molecular Medicine (Course RC817) (E451A) SYLLABUS SYLLABUS
  6. 6. Categorical Course in Diagnostic Radiology: Clinical PET and PET/CT Imaging—Emerging PET Applications (Course RC811) (N228) 10:30-12:00 Scientific Paper Session Nuclear Medicine (Endocrine and Neuroendocrine Imaging) (Session SST05) (E353C) Education Exhibits Space No. Exhibit Title LL-CH3339 Pleural and Extrapleural Malignant Mesothelioma: PET/CT Imaging LL-CH4808 CT and PET/CT Findings of Tumor and Tumor-like Lesions Manifested as an Endotracheobronchial Mass LL-ED1009 Nuclear Medicine Case of the Day Exhibit LL-MI3160 “Silencing of the Genes”: Seminal Role of Tumor Suppressor Genes in Renal and Urothelial Neoplasms LL-MI3161 Molecular Imaging: Translational Research on Clinical Magnetic Resonance Imaging (MRI) Scanning Platforms LL-MI3162 Lymphatic Imaging with Nanoparticles: An Application of Nanomedicine LL-MI3163-H Cancer Cell-specific Optical Molecular Imaging: Strategy and Methods for the Use of “Smart” Fluorescence Probes LL-MI3164 Target-Cell Specific Activatable in Vivo Molecular Imaging of Cancer Foci LL-MI3165 In Vivo Nonlinear Optical Molecular Imaging and Its Clinical Applicability LL-MI3166 Optical Imaging with Molecular Probes: Current Approaches and Future Directions LL-MI4501 p53 in Health and Disease LL-MI4502 Steps of the Drug Discovery Process: The Role of Medical Imaging in the “Omics” Era LL-MI4503 From Bench to Bedside: Introduction to the Practical Application of Cutting Edge Optical Imaging Modalities in Patient Care LL-MS6699 False Positives in FDG-PET and Diffusion-weighted MR Imaging: Benign Lesions and Normal Structures That May Simulate Malignant Tumors LL-NM2731 Spatial Distribution of Sentinel Lymph Nodes Displayed with 3-D Volume-rendering Multimodal Fused Images in Lower Extremity Malignant Skin Tumor LL-NM2732 Utility of SPECT/CT in Localization of Sentinel Nodes in Patients with Melanoma LL-NM2733 Pediatric FDG PET/CT Imaging Pitfalls and Normal Variants SYLLABUS
  7. 7. LL-NM2734 Brown Adipose Tissue in Pediatric FDG PET/CT Imaging LL-NM2735 Easy-to-miss Lesions in MDCT: Lessons Learned from FDG PET-CT Imaging LL-NM2736 Molecular Imaging of Neuroendocrine Tumors with 68 Ga-DOTATOC PET/CT LL-NM2737-L08 Current Role of CT SPECT in Imaging Endocrine Disorders: A Pictorial Review LL-NM2738 Hybrid SPECT-CT: The End of “Unclear” Medicine— A Pictorial Review LL-NM2739 Wide Spectrum of Malignant Lymphoma: New Insight into the Pathogenesis of Lymphoid Malignancies in PET-CT and MRI LL-NM2740 The Decline of the V/Q Empire in the Young: Myth, Reality, or Missed Opportunity? LL-NM2741 Radionuclide Evaluation of the Renal Transplant: Case Examples with Clinical and Multimodality Radiologic Correlation LL-NM2742-H08 Radionuclide Hepatobiliary Imaging: Pearls, Patterns, and Pitfalls LL-NM2743 Radionuclide Imaging of Liver Transplants: Science and Practice LL-NM2744 Scintigraphic Imaging of Body Neuroendocrine Tumors LL-NM2745 Imaging of Peritoneal Carcinomatosis with FDG PET- CT: Diagnostic Patterns, Case Examples, and Pitfalls LL-NM2746 The Clinical Usefulness and Limitations of Full Dose Contrast-enhanced Integrated PET/CT in Gynecologic Malignancies: Case Examples LL-NM2747 Positron Emission Tomography (PET) in Patients with Neurofibromatosis Type 1 (NF1) LL-NM2748 Benign or Malignant? Benign Entities That Can Simulate Malignant Disease on PET/CT LL-NM2749-B08 Diagnostic Integrated I-131 SPECT/CT and F-18 FDG-PET/CT Fusion Imaging in the Evaluation of Differentiated Thyroid Carcinoma: Pictorial Essay LL-NM2750-D08 Differentiating Neoplastic from Non-neoplastic Lung Disease: an Artful Combination of Metabolic (Qualitative and Quantitative FDG on PET) and Morphologic (Multidetector CT) Assessment LL-NM2751 FDG PET-CT in Invasive Transitional Cell Carcinoma of the Urinary Bladder: Spectrum of Typical and Atypical Features LL-NM2752 FDG PET Appearance of Benign and Malignant Bone Lesions LL-NM2753-R08 Whole-body MRI and FDG-PET Fused Images for Evaluation of Patients with Cancer: A Pictorial Essay LL-NM3140 Optimizing PET/CT Differentiation of Inflammation and Infection from Malignancy
  8. 8. LL-NM3141 Diagnosing Musculoskeletal Infection: Integrating Functional and Morphologic Imaging LL-NM3142 Usefulness of FDG PET in Extranodal Malignant Lymphoma Patients LL-NM3143 Selective Internal Radiation Therapy Using Transarterial Rhenium-188 HDD Lipiodol Infusion in Inoperable Hepatocellular Carcinoma: A Primer LL-NM3144 Improved Diagnostic Accuracy of Sternal Wound Infections with SPECT Imaging LL-NM3145 PET/CT Evaluation of Gastric Malignancies: Principles, Techniques, and Clinical Applications LL-NM3146 PET/CT Evaluation of Pancreatic Tumors: Role in Lesion Detection, Staging, and Patient Management LL-NM3147 Adrenal Gland Lesions in Cancer Patients: Advantages and Pitfalls in Interpretation of Intravenous Contrast-enhanced PET/CT LL-NM3148 Fused Image of Computed Tomography and Single Photon Emission Computed Tomography (SPECT): Evaluation of Pulmonary Emphysema LL-NM3149 Spectrum of Extraosseous Accumulation in Bone Scintigraphy: Subtle But Very Important Findings in Daily Diagnosis LL-NM3150-H Homeland Security Instructions for Nuclear Medicine Patients: A Comprehensive and Evidence- based Approach LL-NM3151-D Functional and Anatomic SPECT/CT Imaging: Techniques and Clinical Applications LL-NM3152-B Radioimmunotherapy for Non-Hodgkin Lymphoma: Utilization of This Effective Treatment and Imaging of Treatment Response LL-NM3153 Pictorial Review of the Value of Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) in the Investigation of Pelvic Pressure Sores LL-NM3154-D Role of CT-SPECT in Lymphoscintigraphy for Breast Cancer and Melanoma LL-NM3155 PET/CT Imaging in Oncology: Maximal Utilization of the CT Portion with Contrast Enhancement and Multiphase Data Acquisition LL-NM3156 The Role of PET Imaging in the Detection and Evaluation of Neuroendocrine Tumors LL-UR2668 Recent Advances in the Cytogenetics and the Molecular Biology of the Urinary Bladder Cancers: Impact on Diagnosis and Management LL-UR3095 Congenital Renal Anomalies: What the Radiologist Needs to Know LL-UR3102 Retroperitoneal Fibrosis: A Diagnostic Chameleon and Interventional Challenge LL-UR3105-R Renovascular Disease: Diagnostic Strategy and Postherapeutical Outcome Predictors
  9. 9. Scientific Posters Space No. Poster Title LL-MI4001-B01 Diagnosis of the Graft Rejection in the Xenogeneic and Syngeneic Transplantation of Mice: In Vivo MR Imaging Using the Homing Trait of Macrophages LL-MI4002-B02 Evaluation of Early Therapy Response of an Apoptosis-inducing Antibody in Human Breast Tumors Using Diffusion-weighted Imaging at 9.4T LL-MI4003-B03 Tumor MR Imaging with New Folate Receptor Targeted Contrast Agents LL-MI4004-B04 Diffusion-weighted Imaging in Radiotherapy Follow- up Study: Initial Results on Rabbit VX2 Tumor Model LL-MI4005-B05 Imaging a Novel Oncolytic Vesicular Stomatitis Virus (VSV) by MRI and Bioluminescence LL-MI4007-D01 Quantitative Study of the ADC Value of Normal Human Organs for Whole-body Diffusion-weighted MR Imaging (WB-DWI) LL-MI4008-D02 Effects on Migration and Clonogenic Activity of Human Adult Mesenchymal Stem Cells after Labeling with Superparamagnetic Iron Oxide LL-MI4009-D03 Difference in the Pace of the Recruitment of Macrophages at the Different Stage of Soft Tissue Infection: Quantitative Evaluation with in Vivo MR Image LL-MI4010-D04 Detection of Macrophage Activity in Infected Areas by USPIO-enhanced MRI in an Experimental Vertebral Osteomyelitis Model LL-MI4011-D05 New Macromolecular MRI Contrast Agents for the Clinical Differentiation of Benign Soft Tissues from Breast Cancer Based on Dynamic Assays of Vascular Density and Leakiness LL-MI4012-D06 Gadolinium and Fluorescent Bi-functionally Labeling and in Vitro MR Imaging of Rat Bone Marrow Mesenchymal Stem Cells LL-MI4013-H01 Enhanced Imaging Using PRINT Nanoparticles with Encapsulated Gadolinium Oxide and Iron Oxide LL-MI4014-H02 Optical Imaging of Angiogenesis Markers in an in Vitro Model Mimicking Physiological and Angiogenic Endothelial Cells LL-MI4015-H03 Whole Body Diffusion-weighted MR Imaging (WB-DWI) Compared with PET for Malignant Lymphoma Staging LL-MI4016-H04 CD138 Targeted Super Paramagnetic Nanoparticles: A Potential Multiple Myeloma Specific MR Contrast Agent LL-MI4017-H05 H-MRI Spectroscopy: Urine Profile of Children with Diabetes Type 1 LL-MI4018-H06 Prostate, Breast, and Small-Cell Lung Cancer Detection Using Targeted PET and SPECT Molecular Imaging Agents
  10. 10. LL-MI4019-L01 Characteristics of Gadofluorine M-enhanced MR Imaging in an Ischemic Brain Injury Model of Rat: Initial Experience LL-MI4020-L02 Whole Body Diffusion-weighted MR Imaging (WB- DWI): Technical Improvement and Preliminary Results LL-MI4021-L03 Molecular Imaging with Magnetization Transfer LL-MI4022-L04 Combined 18F-FDG MicroPET/MicroCT for Imaging of Hepatocellular Carcinoma in a Transgenic Murine Disease Model: FDG Uptake Is Correlated with Tumor Size and Gene Expression LL-MI4023-R01 First Experiences of Stem Cell Labeling with Gadofluorine M for a T1-w Positive Cell Imaging Signal LL-MI4024-R02 MR Imaging of Stem Cells in Cartilage Defects LL-MI4025-R03 In Vivo MRI and Optical Imaging Comparison of Viable and Non-viable Mesenchymal Stem Cells with a Bifunctional Label LL-MI4026-R04 Imaging of Endothelin Receptors Utilizing a New Fluorescent Photoprobe LL-MI4027-R05 in Vivo Bioluminescence Imaging: Monitoring of Hypoxia Inducible Factor-1a, A Promoter That Protects Tumor Cells against Hypoxia, in Response to Chemotherapy LL-NM2190-B01 Seasonal Variation of Physiological Myocardial Uptake on Positron Emission Tomography (PET) with F18-fluorodeoxyglucose (FDG) LL-NM2191-B02 Optimization of Quantitative Cardiac PET Acquisition Protocols LL-NM2192-B03 Therapy Decision Planning in a Large Series of Brain Tumors Assessed by F-18 FDG PET LL-NM2193-B04 Integrated 18F-FDG PET/CT Findings in Salivary Gland Type Carcinoma of the Lung LL-NM2194-B05 Assessment of Cross-sectional Lung Ventilation- perfusion Inequality in Smokers with Ventilation/Perfusion Quotient Images Derived from Tc-99m-Technegas/MAA SPECT LL-NM2195-B06 Comparison of FLT PET and FDG PET for the Evaluation of Gastrointestinal Cancer LL-NM2196-D01 The Value of FDG PET-CT in Differentiating Benign from Malignant Pulmonary Nodules LL-NM2197-D02 The Limited Role of FDG-PET for pN1 Nodal Status in Patients with Lung Cancer LL-NM2198-D03 Preoperative FDG-PET for Predicting Early Recurrence of Hepatocellular Carcinoma LL-NM2199-D04 Radiation Necrosis vs Recurrent Tumor Assessment Using Both F-18 FDG PET and MRI LL-NM2200-D05 Unknown Primary Tumors and Paraneoplastic Syndrome: Evaluation with 18F-FDG PET/CT LL-NM2201-D06 Tc99m HMPAO Labeled Leukocyte Imaging in the Assessment of Inflammatory Bowel Disease: Planar versus SPECT
  11. 11. LL-NM2202-D07 Splenic Uptake on FDG PET Increases in Anemia due to Bleeding Caused by Colon Cancer LL-NM2203-H01 The Usefulness of Deep Inspiration Breath-hold F18- FDG-PET/CT Technique in Diagnosing Cancer Located in the Area Affected by Respiratory Motion LL-NM2204-H02 Quantified Evaluation of Tumor Metabolic Volume by Standardized Methods in F18-FDG PET: Accuracy and Reproducibility LL-NM2205-H03 Clinical Implication of Thyroid Incidentalomas: A Comparison of Imaging Modalities with Emphasis on FDG-PET LL-NM2206-H04 Nodal Status of Pelvic and Retroperitoneal Lymphatic Pathways in Patients with Malignant Lymphoma: Comparison of Non-enhanced and Contrast- enhanced Integrated PET/CT LL-NM2208-H06 Evaluation of PET/CT for Suspected Non-small-cell Lung Cancer Diagnosis LL-NM2209-H07 Diagnosis and Monitoring of Takayasu Aortitis: Value of FDG PET LL-NM2210-L01 The Role of [18F]Fluorodeoxyglucose Positron- Emission Tomographic CT (PET-CT) in the Detection of Residual/Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx LL-NM2211-L02 Role of PET-CT Imaging for the Detection of Unknown Primary Tumors LL-NM2212-L03 MRI-Segmented Attenuation Maps for PET Reconstruction LL-NM2213-L04 Comparison of C-11 Acetate PET and F-18 FDG PET in Patients with Hepatocellular Carcinoma LL-NM2214-L05 FDG-PET/CT Using Scopolamine Butylbromide to Reduce Physiologic Uptakes in the Gastrointestinal Tract LL-NM2215-L06 Comparison of Early and Delayed FDG PET for the Evaluation of Malignant Pleural Mesothelioma LL-NM2216-R01 Whole Body Positron Emission Tomography (18FDG PET-CT) in Patients with Unknown Primary with Brain Metastases LL-NM2217-R02 MRI and PET Study of Cerebral Glucose Metabolism and Its Association with Perihematomal Edema Formation after Intracerebral Hemorrhage in Cats LL-NM2218-R03 Inter-Observer Variability between Measurements of the Maximal Standardized Uptake Value on FDG PET/CT and Measurements of the Tumor Size on Diagnostic CT in Patients with Lymphoma LL-NM2219-R04 Incidence of Bone Metastases Detected by Scintigraphy in Liver Transplant Recipients with Known Malignancy LL-NM2220-R05 18FDG-PET/CT in Low Grade NHL LL-NM2221-R06 Discordant Metabolism between Pulmonary Nodules and Lymph Nodes on FDG-PET